DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc.
Zacks Investment Research on MSN
MannKind (MNKD) Reports Break-Even Earnings for Q2
MannKind (MNKD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.04. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for ...
TipRanks on MSN
MannKind completes acquisition of scPharmaceuticals
Corporation completed the previously announced acquisition of scPharmaceuticals (SCPH). The acquisition of scPharmaceuticals is ...
Walleye Capital LLC lessened its holdings in shares of MannKind Corporation (NASDAQ:MNKD – Free Report) by 28.4% in the 1st quarter, according to the company in its most recent Form 13F filing with ...
Under the terms of the definitive merger agreement, MannKind will promptly commence a tender offer to acquire all of the outstanding shares of scPharmaceuticals common stock at a price of $5.35 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback